Patent · US Expired

Production of IBDV VP2 in highly immunogenic form

US5614409A · kind A · utility

4Cited by

3References

18Claims

0Family size

Assignee

COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION · AU

Inventors

Ahmed Abdullah Azad · Melbourne, AU
Ian MacReadie · Melbourne, AU
Neil McKern · Lilydale, AU
Paul Richard Vaughan · Melbourne, AU
Mittur N. Jagadish · Melbourne, AU
Kevin J. Fahey · Melbourne, AU
Antony J. Chapman · Melbourne, AU
Hans G. Heine · Drysdale, AU

Key dates

Filing date	Jan 18, 1994
Grant date	Mar 25, 1997
Priority date	—
Expiry date	Jan 18, 2014

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2720/10022
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A highly immunogenic form of the VP2 structural protein of IBDV comprises a high molecular weight aggregated form of VP2 produced by the expression of a nucleotide sequence coding for the VP2 structural protein or a polypeptide displaying the antigenicity of all or a part of the VP2 structural protein in a yeast or other eukaryotic host cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.